A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A role of microRNA-149 in the prefrontal cortex for prophylactic actions of (R)-ketamine in inflammation model
Authors
Keywords
-
Journal
NEUROPHARMACOLOGY
Volume 219, Issue -, Pages 109250
Publisher
Elsevier BV
Online
2022-09-09
DOI
10.1016/j.neuropharm.2022.109250
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain Research Bulletin Special Issue: Brain–body communication in health and diseases Brain–spleen axis in health and diseases: a review and future perspective
- (2022) Yan Wei et al. BRAIN RESEARCH BULLETIN
- A Systematic Review of Circulatory microRNAs in Major Depressive Disorder: Potential Biomarkers for Disease Prognosis
- (2022) Madiha Rasheed et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers
- (2022) Ellen Scotton et al. BIOCHEMICAL PHARMACOLOGY
- Brain–gut–microbiota axis in depression: A historical overview and future directions
- (2022) Lijia Chang et al. BRAIN RESEARCH BULLETIN
- Inflammation, Lifestyle Factors, and the Microbiome‐Gut‐Brain Axis: Relevance to Depression and Antidepressant Action
- (2022) Francisco Donoso et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A New Player in Depression: MiRNAs as Modulators of Altered Synaptic Plasticity
- (2022) Ya-Nan Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis
- (2022) Xingming Wang et al. NEUROBIOLOGY OF DISEASE
- The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine
- (2022) Li Ma et al. NEURON
- Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota
- (2022) Xiayun Wan et al. NEUROPHARMACOLOGY
- (R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
- (2022) Xingming Wang et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Ketamine as a prophylactic resilience-enhancing agent
- (2022) Audrey G. Evers et al. Frontiers in Psychiatry
- Effects of spleen nerve denervation on depression–like phenotype, systemic inflammation, and abnormal composition of gut microbiota in mice after administration of lipopolysaccharide: A role of brain–spleen axis
- (2022) Li Ma et al. JOURNAL OF AFFECTIVE DISORDERS
- A bibliometric analysis of research on (R)-ketamine from 2002 to 2021
- (2022) Teng He et al. NEUROPHARMACOLOGY
- Arketamine, a new rapid-acting antidepressant: A historical review and future directions
- (2022) Ji-chun Zhang et al. NEUROPHARMACOLOGY
- Emerging role of microRNAs in major depressive disorder and its implication on diagnosis and therapeutic response
- (2021) Lisha Zhou et al. JOURNAL OF AFFECTIVE DISORDERS
- Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
- (2021) Yan Wei et al. MOLECULAR PSYCHIATRY
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- MicroRNA-dependent control of neuroplasticity in affective disorders
- (2021) Helena Caria Martins et al. Translational Psychiatry
- (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation
- (2021) Jiancheng Zhang et al. PSYCHOPHARMACOLOGY
- miR-98-5p plays a critical role in depression and antidepressant effect of ketamine
- (2021) Chaoli Huang et al. Translational Psychiatry
- Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers
- (2021) Yachen Shi et al. EBioMedicine
- The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice
- (2021) Anna Rafało-Ulińska et al. BEHAVIOURAL BRAIN RESEARCH
- A Review on the Role of miR-149-5p in the Carcinogenesis
- (2021) Soudeh Ghafouri-Fard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RhANP attenuates endotoxin-derived cognitive dysfunction through subdiaphragmatic vagus nerve-mediated gut microbiota–brain axis
- (2021) Yuming Wu et al. Journal of Neuroinflammation
- Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
- (2021) Wei Yao et al. MOLECULAR PSYCHIATRY
- MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective
- (2021) Miguel A. Ortega et al. Biomedicines
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- A historical review of antidepressant effects of ketamine and its enantiomers
- (2020) Yan Wei et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
- (2020) Kenji Hashimoto BIOCHEMICAL PHARMACOLOGY
- Assessment of Ketamine and its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness
- (2020) Jackie Zhu et al. International Journal of Environmental Research and Public Health
- A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration
- (2020) Jiancheng Zhang et al. Translational Psychiatry
- MicroRNA-149: a review of its role in digestive system cancers
- (2020) Ning Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
- (2019) Lijia Chang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Prophylactic (R,S)-ketamine selectively protects against inflammatory stressors
- (2019) Alessia Mastrodonato et al. BEHAVIOURAL BRAIN RESEARCH
- MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior
- (2019) Lauren Allen et al. MOLECULAR PSYCHIATRY
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of ( R,S )-ketamine and ( S )-ketamine, but not ( R )-ketamine
- (2018) Zheng Tian et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Regulation of microRNA function in animals
- (2018) Luca F. R. Gebert et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model
- (2017) Youge Qu et al. Scientific Reports
- Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
- (2017) Chun Yang et al. Translational Psychiatry
- Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
- (2016) Rebecca A. Brachman et al. BIOLOGICAL PSYCHIATRY
- Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease
- (2016) Patrick Coit et al. CLINICAL IMMUNOLOGY
- Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
- (2016) Yukihiko Shirayama et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
- (2016) Chun Yang et al. PSYCHIATRY RESEARCH
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Integrating the roles of long and small non-coding RNA in brain function and disease
- (2014) G Barry MOLECULAR PSYCHIATRY
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis
- (2013) Paolo Santini et al. RHEUMATOLOGY INTERNATIONAL
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Metagenomic biomarker discovery and explanation
- (2011) Nicola Segata et al. GENOME BIOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search